RDY

Dr. Reddy's Laboratories Ltd.

Price

$11.73

return (12m)

-19.69%

p/e

26.91

p/bv

2.43

DIVIDEND YIELD

0.60%

RDY price

Dr. Reddy's Laboratories

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment RDY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-23.76%

3 months

-16.13%

1 year

-19.69%

2 years

-27.74%

5 years

-4.39%

10 years

43.40%

Fundamentals RDY

Valuation

P/E

26.91

Sector -2.23

Industry 0.52

P/BV

2.43

Sector 2.14

Industry 2.30

P/Revenue (PSR)

2.73

Sector 1.98

Industry 2.36

EV/EBITDA

70.59

Sector -24.41

Industry -19.03

EV/EBIT

126.51

Sector -37.37

Industry -19.09

P/EBITDA

13.44

Sector -0.01

Industry 1.16

P/EBIT

19.62

Sector -2.00

Industry -0.30

P/Total Assets

1.63

Sector 1.15

Industry 1.24

P/Ativo Circ. Liq.

8.48

Sector -10.54

Industry -12.34

P/Cap.Giro

6.62

Sector 0.02

Industry 3.10

EPS

0.44

Sector -0.94

Industry -0.75

BVPS

4.88

Sector 3.93

Industry 4.90

Efficiency

Gross Margin

53.06%

Sector 44.21%

Industry 49.44%

EBITDA Margin

15.06%

Sector -312.85%

Industry -51.49%

EBIT Margin

8.40%

Sector -193.57%

Industry -51.11%

Operating Margin

11.10%

Sector -25.72%

Industry -28.72%

Net Profit Margins

10.14%

Sector -30.17%

Industry -32.17%

Giro Ativos

0.14

Sector 0.12

Industry 0.14

Profitability

ROE

9.03%

Sector -35.35%

Industry -37.91%

ROA

6.07%

Sector -29.04%

Industry -27.45%

ROIC

2.27%

Sector -439.00%

Industry -96.96%

Dividends

Dividend yield

0.60%

Sector -

Industry -

Payout

16.15%

Sector -

Industry -

Debt

Current Ratio

1.90

Sector 1.87

Industry 1.94

Dívida Líquida/EBITDA

-6.70

Sector -1.64

Industry -4.72

Dívida Líquida/EBIT

-12.01

Sector -0.81

Industry -1.84

Dívida Líquida/Patrimônio

-0.21

Sector -0.35

Industry -0.28

Dívida Bruta/Patrimônio

0.00

Sector 0.17

Industry 0.20

Equity/Assets

0.67

Sector 0.42

Industry 0.45

Liabilities/Assets

0.33

Sector 0.46

Industry 0.51

Growth

5Y Revenue CAGR

5.26%

Sector -

Industry -

5Y Earnings CAGR

0.66%

Sector -

Industry -

FAIR VALUE OF Dr. Reddy's Laboratories ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$11.73

Fair Value

$6.95

Upside Return potential.

-40.72%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals RDY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
RDY	26.91	2.43	9.03%	0.60%	$9.89 B	10.14%
LLY	42.55	34.48	81.02%	0.54%	$1.08 T	34.99%
ISRG	38.26	6.56	17.15%	0.00%	$120.09 B	28.45%
SNY	7.10	1.26	17.79%	4.07%	$105.96 B	14.75%
NVS	23.21	7.06	30.41%	2.00%	$296.12 B	22.50%
TMO	29.78	3.93	13.19%	0.32%	$207.50 B	15.04%
ABT	25.64	3.09	12.06%	0.00%	$160.92 B	13.91%
MDT	22.18	2.13	9.59%	3.43%	$106.51 B	13.20%
GSK	13.15	4.44	33.77%	3.42%	$103.21 B	17.79%
CVS	46.73	1.76	3.78%	2.47%	$137.02 B	0.72%
BSX	18.64	2.57	13.78%	0.00%	$66.45 B	17.29%
TMDX	13.95	4.86	34.80%	0.00%	$2.40 B	27.04%
IDXX	39.73	27.96	70.38%	0.00%	$43.51 B	24.63%
RMD	18.74	4.39	23.41%	1.22%	$28.48 B	27.44%
HCA	12.70	-28.97	-228.14%	0.78%	$86.27 B	8.89%
DHR	33.74	2.57	7.61%	0.54%	$135.09 B	15.95%
SYK	37.64	5.47	14.52%	1.05%	$125.61 B	13.21%
PHG	22.19	1.90	8.56%	3.85%	$25.07 B	5.50%
COHR	117.65	5.01	4.26%	0.00%	$55.16 B	7.10%
INMD	11.06	1.46	13.18%	0.00%	$963.90 M	23.27%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

RDY Historical Dividends

current DY: 0.60%

5-year average DY: 0.62%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	07/09/2025	08/06/2025	0.07150000
Dividends	07/12/2024	08/12/2024	0.09524000
Dividends	07/06/2023	08/11/2023	0.09652000
Dividends	07/07/2022	08/12/2022	0.07568000
Dividends	07/07/2021	08/11/2021	0.06840000
Dividends	07/09/2020	08/17/2020	0.06668000
Dividends	07/11/2019	08/15/2019	0.05644000
Dividends	07/12/2018	08/09/2018	0.05840000
Dividends	07/13/2017	08/10/2017	0.06278000
Dividends	07/14/2016	08/09/2016	0.05990000
Dividends	07/08/2015	08/17/2015	0.06258000
Dividends	07/09/2014	08/15/2014	0.06060000
Dividends	07/10/2013	08/15/2013	0.05280000
Dividends	06/27/2012	08/06/2012	0.04580000
Dividends	06/29/2011	08/11/2011	0.05092000
Dividends	06/14/2011	06/23/2011	0.13206000
Dividends	06/30/2010	08/17/2010	0.04826000
Dividends	07/03/2009	08/12/2009	0.02608000
Dividends	07/04/2008	08/18/2008	0.01776000
Dividends	07/06/2007	08/10/2007	0.01858000
Dividends	07/07/2006	08/21/2006	0.01072000
Dividends	07/07/2005	08/16/2005	0.01148000
Dividends	07/15/2004	08/24/2004	0.01076000
Dividends	08/07/2003	10/02/2003	0.01092000
Dividends	08/08/2002	09/30/2002	0.005100
Dividends	11/21/2001	12/13/2001	0.01042000

ABOUT Dr. Reddy's Laboratories

Dr. Reddy's Laboratories Ltd.

Average Investor10 user rating

4.0 (3 people)

United States

42 years

Founded: 1984

2001

Time since IPO - 25 years

22.740

Employees

Dr. Reddy's Laboratories Ltd. (United States) is listed on the NYSE and has a market capitalization of $9.89 billion, with shareholders equity totaling $4.07 billion.

The company employs approximately 22.740 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Dr. Reddy's Laboratories Ltd. reported $3.63 billion in revenue, generating net income of $367.59 million.

Key financial metrics include a P/E ratio of 26.91, a price-to-book (P/B) ratio of 2.43, and a trailing twelve-month dividend yield of 0.60%.

The company trades under the ticker RDY.

Market cap

$9.89 billion

Net worth

$4.07 billion

$4,072,610,000.00

Assets

$6.06 billion

$6,058,390,000.00

Total Shares Outstanding

834.00 million

834,000,000

Average Daily Trading Volume

$2.58 million

$2,575,912.68

Sector

Health

Industry

Pharmaceutical Products

RDY

RDY revenue and profits

Financial Results RDY

DRAG THE FRAME TO SEE MORE DATA

RDY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$106.93 83,70% (12M)

P/E

46.73

2.47%

ROE

3.78%

P/BV

1.76

CI - Cigna

$292.00 1,25% (12M)

P/E

11.72

2.13%

ROE

15.39%

P/BV

1.80

CNC - Centene

$64.13 125,89% (12M)

P/E

-4.85

0.00%

ROE

-29.93%

P/BV

1.45

HUM - Humana

$384.26 63,80% (12M)

P/E

41.90

0.67%

ROE

6.06%

P/BV

2.54

SNY - Sanofi

$44.31 --8,57% (12M)

P/E

7.10

4.07%

ROE

17.79%

P/BV

1.26

LLY - Eli Lilly

$1,198.69 49,60% (12M)

P/E

42.55

0.54%

ROE

81.02%

P/BV

34.48

HCA - HCA Healthcare

$389.58 17,30% (12M)

P/E

12.70

0.78%

ROE

-228.14%

P/BV

-28.97

NVS - Novartis

$156.65 35,68% (12M)

P/E

23.21

2.00%

ROE

30.41%

P/BV

7.06